Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention

By sjmartinez • January 14, 2023

Nicholas SB, Cervantes L; Clinical Care & Innovation Workgroup of the American Society of Nephrology Health Care Justice Committee. Health Care Equity and Justice Scorecard To Increase Diversity in Clinical Trial Recruitment and Retention. J Am Soc Nephrol. 2022 Sep;33(9):1652-1655. doi: 10.1681/ASN.2022040427. Epub 2022 Jun 29. PMID: 35768179; PMCID: PMC9529187.

Tags: Chronic kidney disease, Clinical Trial, community engagement, Diversity, Nephrology, patient partners, Publications, racial and ethnic disparities

Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning

Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, Chattopadhyay A, Sinha SK, Reddy ST, Singh R. Follistatin Mitigates Atherosclerosis Through Activation[...]

Cardiovascular outcomes of empagliflozin-GLP-1RA combination therapy in type 2 diabetes: EMPRISE study

Htoo PT, Cho H, Paik JM, Bykov K, Everett BM, Glynn RJ, Shay C, Schmedt N, Wexler DJ, Patorno E. Cardiovascular outcomes of empagliflozin-GLP-1RA combination[...]

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]